A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug that can ...

According to Liu, his preferred option is faricimab, a fairly new agent that was FDA-approved for wet AMD in 2022. The drug ...

(Reuters) -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million, granting the pharma giant ...

Gold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could potentially treat age-related macular degeneration (AMD) and other eye problems. "This ...

CHICAGO — Specialists are losing money with every intravitreal injection they administer, regardless of the drug being injected, an investigator warns. Each injection we do costs $127.74 — $1.60 for ...

August 2, 2012 — Using a microneedle to inject drugs into the suprachoroidal space may provide a method for drug delivery to the posterior segment of the eye that is less invasive and more targeted ...

A father with a progressive eye disease was able to see his son thanks to a new therapy that uses a virus to bring a healthy gene into the eye CBS 17/YouTube A dad with the degenerative eye disease ...

Bispecific antibody treatments remain a promising treatment for diabetic macular edema (DME), as a new study shows that faricimab was effective and had durable results after a year of real-world ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Dr. Andreas Wallnöfer joins Optigo Biotherapeutics' Board, bringing expertise from Jeito Capital, BioMedPartners, and Roche.

Lawsuits involving intravitreal injections seem to be rare despite millions of procedures being done each year. In a review of 60 lawsuits, manufacturers and compounding pharmacies were sued more ...